Cystatin C as a predictor of renal recovery and in hospital mortality in patients with acute kidney injury and liver cirrhosis
Abstract Background Acute kidney injury (AKI) is a common and serious complication in patients with liver cirrhosis, with pre-renal AKI and acute tubular necrosis being the most frequent underlying causes. Cystatin C is a non-glycosylated 13 kDa protein that is consistently produced by all nucleated...
Saved in:
| Main Authors: | Eman Nagy, Ahmed H. Abdelfattah, Nagy Sayed-Ahmed, Sadiq Ahmed |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Nephrology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12882-025-04341-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cystatin C: diagnostic and prognostic value in acute kidney injury
by: D. I. Korabelnikov, et al.
Published: (2024-08-01) -
Cystatin C: factors affecting diagnostic and prognostic value in acute kidney injury
by: M. O. Magomedaliev, et al.
Published: (2024-11-01) -
Assessment of renal dysfunction in patients with cirrhosis
by: A. S. Tugushev, et al.
Published: (2015-12-01) -
Outcome prediction of sepsis-induced acute kidney injury by plasma endostatin: prospective observational study
by: Farouk Mostafa Faris, et al.
Published: (2025-07-01) -
The Predictive Value of Cystatin C for AKI in Patients with COVID-19
by: M. O. Magomedaliev, et al.
Published: (2023-04-01)